Literature DB >> 10961621

Predictive value of MRI-identified mesial temporal sclerosis for surgical outcome in temporal lobe epilepsy: an intent-to-treat analysis.

F Gilliam1, E Faught, R Martin, S Bowling, E Bilir, J Thomas, R Morawetz, R Kuzniecky.   

Abstract

PURPOSE: Magnetic resonance imaging (MRI) accurately identifies mesial temporal sclerosis (MTS), but prediction of successful surgical outcome ranges from 62% to 96% in published studies. Prior investigations only used patients who had received anterior temporal lobectomy (ATL), potentially overestimating the predictive value of MRI-identified MTS (MRI-MTS).
METHODS: The authors performed an intent-to-treat analysis of 90 consecutive patients assessed for possible ATL, including 13 who did not undergo ATL because of inconclusive intracranial ictal EEG. Four (31%) of these 13 patients had unilateral mesial temporal abnormalities on their MRIs.
RESULTS: The positive predictive value of MRI-MTS for seizure cessation decreased from 0.69 to 0.63 after adjustment for these additional false positive results. Four previous studies had revealed a positive predictive value of 0.75 (0.72 after similar adjustment).
CONCLUSIONS: The authors conclude that the predictive value of MRI-MTS for outcome from ATL may be overestimated by small retrospective studies of highly selected postoperative patients.

Entities:  

Mesh:

Year:  2000        PMID: 10961621     DOI: 10.1111/j.1528-1157.2000.tb00279.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  2 in total

Review 1.  Structural magnetic resonance imaging in epilepsy.

Authors:  Karel Deblaere; Eric Achten
Journal:  Eur Radiol       Date:  2007-09-25       Impact factor: 5.315

2.  Long term outcome of temporal lobe epilepsy surgery: analyses of 140 consecutive patients.

Authors:  L Jutila; A Immonen; E Mervaala; J Partanen; K Partanen; M Puranen; R Kälviäinen; I Alafuzoff; H Hurskainen; M Vapalahti; A Ylinen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-11       Impact factor: 10.154

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.